PepGen Stock Craters 35% on FDA Clinical Hold

Seeking AlphaDec 16 22:56

Express News | Dyne Therapeutics Inc : Baird Initiates Coverage With Outperform Rating; Target Price $46

BreakingsDec 13 15:12

Baird Initiates Dyne Therapeutics(DYN.US) With Buy Rating, Announces Target Price $46

Futu NewsDec 13 05:31 · Ratings

Dyne Therapeutics(DYN.US) Director Sells US$3.99 Million in Common Stock

$Dyne Therapeutics(DYN.US)$ Director Kersten Dirk sold 136.11K shares of common stock on Dec 6, 9, 2024 at an average price of $29.3 for a total value of $3.99 million.Source: Announcement What is

Futu NewsDec 11 05:11

Dyne Therapeutics Director Kersten Dirk Sells 138,845 Shares At An Average Price Of $29.38 Per Share

BenzingaDec 7 05:13

Dyne Therapeutics(DYN.US) Director Sells US$4.08 Million in Common Stock

$Dyne Therapeutics(DYN.US)$ Director Kersten Dirk sold 138.85K shares of common stock on Dec 4, 5, 2024 at an average price of $29.38 for a total value of $4.08 million.Source: Announcement What is

Futu NewsDec 7 05:12